,\uguost, 1995

STUART C. FINCH, M.D.

Date & Place of Birth;

3Marital Status:

Home Address:

Home Telephone:

Education:

Dartmouth College, Hanover, New Hampshire. Univ. of Rochester School of Medicine & Dentistry, Rochester, New York, M.D.

Career:

Major Appointments:

Intern in Surgery, Baltimore City Hospitals, Baltimore, Maryland. Resident in Pathology, Baltimore City Hospitals, Baltimore, Maryland.

Teaching Assistant in Pathology, University of Maryland Medical School, Baltimore, Maryland.

First Lieutenant and Captain in the U.S. Army Medical Corps in Japan.

Research Assistant in Medicine, Harvard Medical School, Boston, Massachusetts.

Resident in Medicine, Peter Bent Brigham Hospital, Boston, Massachusetts.

Fellow in Medicine (Hematology), Massachusetts Memorial Hospital, Boston, Massachusetts.

1944-45 1945-46 1945-46 1946-48 1948-49 1949-50 1950-53

Social Security Number:

Business Address:

Cooper Hospital/ University Medical Center One Cooper Plaza Camden, NJ 08103

Business Telephone:

(609) 342-2206

Fax Number:

mo"9

1952-53 Instructor in Medicine, Boston University Medical School, Boston, Massachusetts. 1953-59 Assistant Professor of Medicine, Yale University School of Medicine, New Haven, Connecticut.

1959-67 Associate Professor of Medicine, Yale University School of Medicine, New Haven, Connecticut.

1960-62 Chief of Medicine, Atomic Bomb Casualty Commission, Hiroshima, Japan (on leave of absence from Yale).

1967-77 Professor of Medicine, Yale University School of Medicine, New Haven, Connecticut. 1974-75 Special Consultant to the Director, Atomic Bomb Casualty Commission, Hiroshima, Japan (6

month leave of absence from Yale. September 1974-February 1975). 1975-77 Chief of Research and a Permanent Director, Radiation Effects Research Foundation, Hiroshima,

Japan (2 year leave of absence from Yale from August 1975-September 1977). 1977-79 Clinical Professor of Medicine, Yale University School of Medicine, New Haven, Connecticut. 1977-79 Vice Chairman, Chief of Research, and a Permanent Director, Radiation Effects Research

Foundation, Hiroshima, Japan. 1979-86 Chief of Medicine, Cooper Hospital/University Medical Center, Camden, New Jersey. 1979-86 Head of the Department of Medicine, (UMDNJ-Rutgers Medical School at Camden, 1979 -85,

UMDNJ-Robert Wood Johnson Medical School at Camden, 1985-86). 1979-85 Professor of Medicine, University of Medicine & Dentistry of New Jersey-Rutgers Medical

School. 1985- Professor of Medicine, University of Medicine & Dentistry of New Jersey-Robert Wood Johnson

Medical School. 1986-88 Chief of Research and a Permanent Director, Radiation Effects Research Foundation, Hiroshima,

Japan (2 year leave of absence from the University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School).

1988- Vice President for Research Development, Cooper Hospital/University Medical Center.

Current and Previous Attending-Consulting Positions:

1953-77 Consultant, Veterans Administration Hospital, West Haven, Connecticut. 1953-77 Attending Physician, Yale-New Haven Hospital, New Haven, Connecticut. 1955-77 Consultant in Hematology, Meriden-Wallingford Hospital, Meriden, Connecticut. 1955-77 Consultant in Hematology, Milford Hospital, Milford, Connecticut. 1955-77 Consultant in Hematology, William W. Backus Hospital, Norwich, Connecticut. 1955-77 Consultant in Hematology, Hospital of St. Raphael, New Haven, Connecticut. 1958-77 Consultant in Hematology, Laurel Heights Sanatorium, Shelton, Connecticut. 1960-77 Consultant in Hematology, Lawrence and Memorial Hospitals, New London, Connecticut. 1965-77 Consultant in Hematology, St. Vincent's Hospital, Bridgeport, Connecticut. 1977-80 Consultant to Geriatric Research, Education and Clinical Center, Veterans Administration

Wadsworth Hospital Center, Los Angeles, California.

Appointments, Committees, Etc.:

1957-59 Council of the American Federation for Clinical Research.

2

1957-59 Secretary. Eastern Section of the American Federation of Clinical Research.

1958-70 Connecticut Chapter of the National Hemophilia Foundation, Medical Advisory Board

(Chairman, 1964).

1958-65 Blood, Advisory Editorial Board.

1962-75 Atomic Bomb Casualty Commission, Hiroshima, Japan, Consultant in Hematology.

1962-70 Medical Advisory Board to the Atomic Bomb Casualty Commission, National Academy of

Sciences.

1964-66 Connecticut Division of the American Cancer Society, Professional Education Committee.

1966-68 Connecticut Division of the American Cancer Society, Service and Rehabilitation Committee

(Chairman: 1967-68).

1966-74 International Health Committee, Yale University School of Medicine, New Haven, Connecticut.

1967-71 Jane Coffin Childs Memorial Fund for Medical Research, New Haven, Connecticut, Assistant

Director.

1967-77 Silliman College, Yale University, New Haven, Connecticut, Fellow.

1968-74 Connecticut Division of the American Cancer Society, Medical Advisory Board, (Chairman:

1968-70).

1968-75 Connecticut Division of the American Cancer Society, Executive Committee.

1968-70 National Leukemia Society, Medical Advisory Board.

1969-72 Admissions Committee, Yale University School of Medicine, New Haven, Connecticut.

1970-76 Blood and Hemopoietic System Evaluation Committee, Veterans Administration, Washington,

D.C. 1970-75 Committee on Regional Activities, Yale University School of Medicine, New Haven,

Connecticut (Chairman 1973-75).

1972-75 Secretary, Class of 1942, Dartmouth College, Hanover, New Hampshire.

1972-76 Yale-China. Board of Trustees and Chairman of the Medical Board.

1972-75 Cooley's Anemia Foundation, Connecticut Chapter, Medical Advisory Board.

1973-76 Alumni Council, University of Rochester School of Medicine and Dentistry (Vice Chairman,

1974; Chairman, 1975).

1974-75 Dartmouth Club of New Haven, President.

1979- Medical Committee, New Jersey Division of the American Cancer Society (Vice Chairman,

1981-83), (Chairman, 1983-85).

1980- Class Agent, Dartmouth College, Class of 1942.

1981-86 Associate Editor, Camden County Medical Society Bulletin.

1981-83 Southwest New Jersey Consortium for Health Information Services, Board of Directors

(President, 1982-83).

1981-86 Professional Education Committee of the Camden County Unit of the American Cancer Society.

1983-92 Advisory Committee on the Radiation Effects Research Foundation, Commission on Life

Sciences, National Research Council

1983-86 Board of Managers of the Camden County Unit of the American Cancer

Society. 1983- Executive Committee, New Jersey Division of the American Cancer Society.

1985-86 Public Issues Committee of the Camden County Unit of the American Cancer Society (Vice

Chairman).

1985-89 Planning and Executive Committees, New Jersey Division of the American Cancer Society.

3

1987-89 President Elect, New Jersey Division of the American Cancer Society.

1989-92 Advisory Board of Managers, Camden County Unit of the American Cancer Society.

1989-91 President, New Jersey Division of the American Cancer Society.

1990-91 Editorial Advisory Board for Oncology in Practice.

1991-92 Medical Delegate from New Jersey, National Board of Delegates, American Cancer Society.

1991-93 Planning Committee, (Chairman) New Jersey Division of the American Cancer Society.

1991-93 Professional Education Committee, (Vice Chairman) New Jersey Division of the American

Cancer Society. 1991-94 Committee memberships (Nominating and Professional Education) New Jersey Division of the

American Cancer Society.

1991- Committee memberships (Personnel-Chairman 1994 & 1995, Planning, Field Services and

Finance) New Jersey Division of the American Cancer Society.

1991- Executive Committee for ASSIST 2000, New Jersey Division of the American Cancer Society.

1991- Committee for the Study of Leukemia in the Ukraine, National Institutes of Health.

1991- Board of Directors, New Jersey Division, American Cancer Society.

1992-94 Committee on Radiological Safety in the Marshall Islands, (Vice Chairman) National Research

Council. 1992- Medical Delegate Director, National Board of Directors, American Cancer Society.

1992- Medical Affairs Committee, National Board of Directors, American Cancer Society.

1993- Board of Managers of the Camden County Unit of the American Cancer Society.

1994- Committee on International Cooperation in Cancer Control, National Board of Directors,

American Cancer Society.

1994- Research and Clinical Investigation Committee, National Board of Directors, American Cancer

Society. 1994- Scientific Policy Council of the International Consortium for Research on the Health Effects of

Radiation

1994- Board of Directors, The New Jersey Association for Biomedical Research

1995- Skin Cancer Advisory Group, National Board of Directors, American Cancer Society.

1995- Workgroup on International Activities, National Board of Directors, American Cancer Society.

1995- International Partners in Cancer Control Sub-committee, National Board of Directors, American

Cancer Society.

1995- Physician Advisory Task Force Member, New Jersey Division, American Cancer Society.

Professional Societies:

1950- International Society of Hematology

1952- American Federation for Clin:"al Research (Emeritus, 1966)

1953- Sigma XI

1953- American Society of Hematology

1955- American Association for the Advancement of Science

1958- American Society of Clinical Investigation (Emeritus, 1986)

1958- American Association for Cancer Research

1958- Society for the Study of Blood (Emeritus, 1991)

4

19581958-77 1962-66 1963-70 19641965-77 1965-86 1968-77 1979198019801980-86 1981-86

Honors and A

1962 1966 1967 1967 1986 1988 1991 1992 1992 1992 1994

Interurban Clinical Club (Emeritus. 1986)

Beaumont Society Japan Society of Hematology

International Society for Experimental Hematology

American Association of Physicians (Emeritus, 1993)

New Haven Medical Society (Cabinet member)

American Medical Association

Southern Connecticut Association for Blood

New Jersey Medical Society

The College of Physicians of Philadelphia (Emeritus, 1992)

Camden County Medical Society

American Society of Internal Medicine

New Jersey Society of Internal Medicine

.wards:

Certificate of Appreciation, Hiroshima Medical School, (First Foreign Visiting Professor).

Certificate of Appreciation, National Hemophilia Foundation.

Humanitarian Award, Connecticut Chapter of National Hemophilia Foundation.

Master of Arts Privatim, Yale University.

Certificate of Appreciation, Class of 1986, Rutgers Medical School.

Certificate of Appreciation, Radiation Effects Research Foundation, Japan.

Leadership Medal, New Jersey Division of the American Cancer Society.

Phi Beta Kappa, Dartmouth College.

Physician of the Year, New Jersey Division of the American Cancer Society.

Citizen of the Month (October), .Star-Ledger Newspaper.

Certificate of Appreciation, Albert Schweitzer Institute for the Humanities

Board Ce rtiticatbon anu L icutei1uO. bi 57

The Commonwealth of Massachusetts, Board of Registration in Medicine_23178), October 3, 195

State of Connecticut, License for the practice of Medicine and Surgery, (#7226), September 3, 1953.

American Board of Internal Medicine, Certification in Internal Medicinet•#i2570), September 25, 1956.

State of N-w Jersey, License in Medicine and Surgery (#36516), August 2, 1

Military Service:

# "W Served as a First Lieutenant and Captain in the U.S. Army Medical Corps in Japan.

5

PUBLICATIONS

1. Finch, S.C., Haskins, D., Finch,C.A.: Iron metabolism. Hematopoiesis following phlebotomy.

Iron as a limiting factor. J. Clin. Invest., 29, 1078- 1086, 1950.

2. Finch, C.A., Hegsted, M., Kinney, T.D., Thomas, E.D., Rath, C.E., Haskins, D., Finch,

S.C., Fluharty,R.G.: Iron metabolism. The pathophysiology of iron storage. Blood,

5:983-1008, 1950.

3. Finch, S.C., Crockett, C.L., Jr., Ross, J.F., Bayles, T.B.: Hematologic changes with ACTH

and cortisone therapy of rheumatoid arthritis. Blood 6:1034- 1050, 1951.

4. Finch, S.C., Crockett, C.L., Jr., Ross, J.F., Bayles, T.B.: Hematologic changes with ACTH

and cortisone therapy of rheumatoid arthritis. Pro Second Clin. ACTH Conference, Blakiston

Co., 1951, pp.589-5 9 8 .

5. Finch, S.C.: Vitamin B12 in medicine. Med. Clin. North Am. 36:1223-1237, 1252.

6. Haskins, D., Stevens, A.R., Jr., Finch, S.C., Finch, C.A.: Iron metabolism. Iron stores in man

as measured by phlebotomy. J. Clin. Invest. 31,543-547, 1952.

7. Finch, S.C., Ross, J.F., Ebaugh, F.C., Jr.: Immunologic mechanisms of leukocyte

abnormalities. J.Lab. Clin. Med., 42:555-569, 1953.

8. Ross, J.F., Barger, A.C., Finch, S.C., Ross, R.S., Price, H.L., Freireich, E.J.: The blood

volume before and following experimentally produced congestive heart failure in dogs. Trans.

Assoc. Am. Physicians 66:278-293, 1953.

9. Ross, J.R., Crockett, C.L., Jr., Finch, S.C., Emerson, C.P.: The mechanism of anemia in

leukemia and malignant lymphoma. Boston Med. Quart. 5:8-10, 1954.

10. Ross, J.R., Finch, S.C., Street, R.B., Jr., Strieder, J.W.: The simultaneous occurrence of

benign thymoma and refractory anemia. Blood, 9:935-952, 1954.

11. Cajano A., Miller, A., Finch, S.C., Ross, J.F.: Autoimmunization to blood cells. Le Sang

26:141, 1955.

12. Cajano, A., Miller, Al, Finch, S.C., Ross, J.F.: Auto-immunizzazione per cellule ematiche:

Primi Risultati di Richerche Sperimetali, Estratto dal Bollettino della Societa Italiana di

Ematologia Vol. III, Fasc. 2, 1955.

13. Finch, S.C., Cajano, A., Ross, J.F.: Leukocyte response to leukocyte nuclear and cytoplasmic

antisera. J. Lab Clin. Med., 46:871-878, 1955.

6

14. Hollingsworth, J.W., Finch, S.C.: Leukocyte response to granulocyte fraction antisera. J. Lab

Clin. Med., 46:879-884, 1955.

15. Finch, S.C., Finch, C.A.,: Idiopathic hemochromatosis, an iron storage disease: A. iron

metabolism in hemochromatosis. Medicine, 34:381-430, 1955.

16. Isham, R.L., Finch, S.C.: Postabortal clostridium welchii sepsis with massive hemolysis:

Report of a case. N. Engl. J. Med., 254:317-320, 1956.

17. Hollingsworth, J.W., Finch, S.C., Chang, C.H.: Study of leukocyte dynamics by means of

cross-circulation between normal and leukopenic rats. Blood. 11:665- 672, 1956.

18. Hollingsworth, J.W., Finch, S.C., Beeson, P.B.: The role of transfused leukocytes in

experimental bacteremia of irradiated rats. J. Lab Clin.. Med., 48:227-236, 1956.

19. Finch, S.C.: The indications for and hazards of blood transfusions. Conn. State Med. J.

20:886-892, 1956.

20. Finch, S.C.: Antigenicity of leukocyte fractions in the Leukemias: Etiology.

Pathophysiology, and Treatment.. New York, Academic Press, Inc., 1957, pp. 6 1-6 5 .

21. Hollingsworth, J.W., Finch, S.C.: Viability and distribution of leukocytes Following

cross-circulation experiments between leukemic and normal or irradiated rats. Blood.

12:140-146, 1957.

22. Hollingsworth, J.W., Finch, S.C.: Leukocyte changes during acute cross- circulation

experiments between leukemic and normal or irradiated rats. Blood.

12:130-139, 1957.

23. Hollingsworth, J.W., Berend, J.A., Silbert, D.R., Finch, S.C.: Leukocyte mobilization in

normal splenectomized and leukemic rats after replacement transfusion. J.Lab. Clin. Med.

50:36-44, 1957.

24. Finch, S.C., Barnett, R.N.: Diagnostic and therapeutic phlebotomy in hemochromatosis with

anemia. Report of a case. N.Eng. J. Med. 256:884, 887, 1957.

25. Freireich, E.J., Ross, J.F., Bayless, T.B., Emerson, C.P., Finch, S.C.: Radioactive iron

metabolism and erythrocyte survival studies of the mechanism of the anemia associated with

rheumatoid arthritis. J. Clin. Invest.

36:1043-1058, 1957.

26. Shanbrom, E., Finch, S.C.: Adverse effects of methyltestosterone in lymphomas. Cancer.

10:964-970, 1957.

7

27. Friou, G.J., Finch, S.C., Detre, K.D.: Interaction of nuclei and globulin from lupus

erythematosus serum demonstrated with fluorescent antibody. J. Immunol. 80:324-329, 1958.

28. Detre, K.D.', Finch, S.C.: Radiation-protective effects of yeast extract and yeast ribonucleic

acid. Science. 128:656-657, 1958.

29. Shanbrom, E., Finch, S.C.: The auditory manifestations of leukemia. Yale J. Biol. Med

31:144-156, 1958.

30. Finch, S.C., Detre, K.D.: The localization and action of leukocyte antibody. Vox. Sang. 3:42,

1958.

31. Finch, S.C.: Transmission of leukemia. Progress in Hematology III 192-205, Grune Stratton,

New York, 1959.

32. Finch, S.C.: Special therapeutics (Transfusions). Ann. Rev. Med. 10:307-328, 1959.

33. Finch, S.C., Hollingsworth, J.W.: Cross-circulation experiments in elucidating the viability and

distribution of leukocytes. Ann. NY Acad. Sci. 77;431-444, 1959.

34. Rigas, D.A., Finch, S.C.: Electrophoretic studies of serum proteins in hemochromatosis. Am.J.

Med. Sci. 237:566-573, 1959.

35. Brody, J.1., Finch, S.C.: Bone marrow needle biopsy. Am.J. Med. Sci. 238:140- 145, 1959.

36. Brody, J.1., Finch, S.C.: Candida-reacting antibody in the serum of patients with lymphomas

and related disorders. Blood. 15:830-839, 1960.

37. Perillie, P.E., Calabresi, P., Finch, S.C.: Demonstration of L.E. cells at local inflammatory

sites in patients with systemic lupus erythematosus. N. Engl. J. Med. 263:1052-1055, 1960.

38. Calabresi, P., Brody, J.I., Perillie, P.E., Finch, S.C.: Clinical experiences with 5-fluorouracil.

Conn. Med. 24:415-421, 1960.

39. Perillie, P.E., Finch, S.C.: The local exudative cellular response in leukemia J. Clin. Invest.

39:1353-1357, 1960.

40. Welch, A.D., Handschumacher, R.E., Finch, S.C., Jaffee, J.J., Cardoso, S.S., Calabresi, P.:

A synopsis of recent investigations of 6-azauridine. Cancer Chemotherapy Reports. 9:39-46,

1960.

41. Finch, S.C.: Cancer Chemotherapy, Hiroshima Igaku. 13:1087-1090, 1960.

42. Brody, J.1., Finch, S.C.: Improvement of Factor X deficiency during pregnancy. N.Engl.J.

8

Med. 263:996-999, 1960.

43. Brody, J.I.,, Finch, S.C., Nelligan, D.: Management of obstructive jaundice in chronic

lymphocytic leukemia. Am. J. Med. Sci. 240:726-731, 1960.

44. Finch, S.C., Perillie, P.E., Detre, K.D.: Mobilization and function of leukemic leukocytes in

response to inflammation. Proc. VIII Int. Congr. Hematology. Pan Pacific Press, Tokyo,

Japan. 2:775-776, 1960.

45. Finch, S.C., Brody, J.I.: Immune adherence characteristics of erythrocyte and platelet antibody.

Proc. VIII Int. Congr. Hematology. Pan Pacific Press, Tokyo, Japan. 3:12439-1441, 1960.

46. Calabresi, P., Cardoso, S.S., Finch, S.C., Kilgerman, M.D., von Essen, C.F., Chu, M.Y.,

Welch, A.D.: Initial clinical studies with 5-iodo-2-deoxyuridine. Cancer Res. 21:550-559, 1961.

47. Brody, J.I., Finch, S.C.: Serum factors of acquired hemolytic anemia in leukemia and

lymphoma. J. Clin. Invest. 40:181-187, 1961.

48. Perillie, P.E., Finch, S.C.: Alkaline phosphatase activity of exudative leukocytes in acute

leukemia. Blood. 18:181-187, 1961.

49. Niwayama, G., Finch, S.C.: A case of primary carcinoma of the left lung with marked upper

mediastinal compression symptoms. Hiroshima Iagku. 14:789-798, 1961.

50. Finch, S.C.: A brief review of the ABCC medical program. Hiroshima Igaku. 15:1-7, 1962.

51. Perillie, P.E., Nolan, J.P., Finch, S.C.: Studies of the resistance to infection in diabetes

mellitus: local exudative cellular response. J. Lab. Clin. Med. 59:1008-1015, 1962.

52. Perillie, P.E., Finch, S.C.: Quantitative studies of the local exudative cellular reaction in acute

leukemia. J.Clin. Invest. 43:425-430, 1964.

53. Finch, S.C.: Recognition and clinical importance of thorium dioxide (Thorotrast) deposits in

human unstained bone marrow smears. Yale J. Biol. Med. 36:388-395, 1964.

54. Finch, S.C., Lamphere, J.P., Jablon, S.: The relationship of serum lysozyme to leukocytes and

other constitutional factors. Yale J. Biol. Med. 36:350-360, 1964.

55. Finch, S.C., Gnabasik, F.J., Rogoway,W.: Lysozyme and leukopoiesis. Proc. Third. Int.

Congr. on Fleming's Lysozyme. Milano, Italy, 1964.

56. Finch, S.C., Gnabasik, F.J., Rogaway, W.: The relationship between serum lysozyme and

leukocyte turnover. Med. et Hyg. 22:972-974, 1964 (French).

9

57. Finch, S.C.: Infectious mononucleosis in Immunological Disease, M. Samter (editor), Little,

Brown, & Company, Boston, 1965, pp. 394-402.

58. Finch,S.C.: Anemia due to iron deficiency, in Current Therapy, W.B. Saunders, Co.,

Philadelphia and London, 1965, pp. 185-187.

59. Fischer, D.S., Finch, S.C.: Infectious mononucleosis: A 1965 viewpoint. Conn. Med.

29:581-586, 1965.

60. Groch, G.S., Perillie, P.E., Finch, S.C.: Reticuloendothelial phagocytic function in patients

with leukemia, lymphoma and multiple myeloma. Blood. 26:489-499, 1965.

61. Kra, S.J. ,Hollingsworth, J.W., Finch, S.C.: Arthritis with synovial iron deposition in a patient

with hemochromatosis. N. Engl. J. Med. 272:1268-1271, 1965.

62. Binder, H.J., Herting,D.O., Hurst, V., Finch, S.C., Spiro, H.M.: Tocopherol deficiency in

man. N. Engl. J. Med. 273:1289-1297, 1965.

63. Perillie, P.E., Finch, S.C.: Recent advances in leukemia therapy. Conn. Med 30:562-566,

1966.

64. Briggs, R.S., Perillie, P.E., Finch, S.C.: Lysozyme in bone marrow and peripheral blood cells.

J. Histochem. Cytochem. 14:167-170, 1966.

65. Groch, G.S., Finch, S.C., Rogoway, W., Fischer,D.S..: Studies in the pathogenesis of

autoerythrocyte sensitization syndrome. Blood. 28:19-33, 1966.

66. Gnabasik, F.J., Groch, G.S., Dineen, J.J., Finch, S.C.: A disposable micropipet method for

performing reticuloendothelial clearance studies in small animals. Am. J. Clin. Pathol.

45:93-95, 1966.

67. Gryboski, J.D., Finch, S.C.: Placental barrier to the fetal transfer to maternal chloroleukemia

in rats. Proc. Soc. Exp, Biol. Med. 121:441-444, 1966.

68. Kanamitsu, M., Morita, K., Finch, S.C., Kato, H., Onishi, S.P.: Serologic

response of atomic bomb survivors following Asian influenza vaccination. Jpn. J. Med. Sci,

Biol. 19:73-84, 1966.

69. Binder, H.J., Spiro, H.M., Finch, S.C.: Autohemoloysis in tocopherol deficiency secondary

to steatorrhea. Am. J. Med. Sci. 252:686-688, 1966.

70. Finch, S.C., Lamphere, J.P., Jablon, S.: ABCC-JNIH Adult Health Study, Hiroshima: Serum

lysozyme determinations. Hiroshima Igaku 29:85-93, 1966.

10

71. Perillie, P.E., Finch, S.C.: Infection in leukemia. Medical Digest, 13:63-66, 1967.

72. Perillie, PRE., Finch, S.C.: Histochemical studies on leukocyte alkaline phosphatase in

non-leukaemic granulocytosis: Effects of anticoagulants and role of zinc and magnesium. Br.

J. Haematol. 13:289-293, 1967.

73. Finch, S.C.: Recognition of radiation-induced late bone marrow changes. Ann. NY Acad. Sci.

145:748-754, 1967.

74. Perillie, P.E., Kaplan, S.S. ,Finch, S.C.: Significance of changes in serum muramidase activity

in megooblastic anemia. N. Engl. J. Med. 227:10- 12, 1967.

75. Hoshino, T., Kato, H., Finch, S.C., Hrubec, Z.: Leukemia in offspring of atomic bomb

survivors. Blood 30:719-730, 1967.

76. Dineen, J.J., Perillie, P.E., Finch, S.C.: Zymosan-induced throbocytopenia in the rat. J.

Reticuloendothel. Soc. 161-174, 1968.

77. Fink, M.E., Finch, S.C.: Serum muramidase and granulocyte turnover. Pro. Soc. Exp. Biol.

Med. 127:365-367. 1968.

78. Cooper, M., Briggs, R.S., Finch, S.C.: Therapy of refractory idiopathic thrombocytopenic

purpura. Conn. Med. 32:509-513, 1968.

79. Fischer, D.S., Finch, S.C.: Evaluation of purpura in women. Conn. Med. 32:514-518, 1968.

80. Kaplow, L.S., Finch, S.C., Bertino, J.R.: Some enzyme changes of clinical importance in

leukemia. Conn. Med. 32:519-522, 1968.

81. Perillie, P.E., Kaplan, S.S., Lefkowitz, E., Rogaway, W., Finch, S.C.: Studies of muramidase

(lysozyme) in leukemia. JAMA. 203:79-84, 1968.

82. Hayslett, J.P., Perillie, P.E., Finch, S.C.: Urinary muramidase and renal disease: Correlation

with renal histology and implication for the mechanism of enzymuria. N. Engl. J. Med.

279:506-512, 1968.

83. Finch, S.C.: Granulocytes in Chediak-Kigashi syndrome (editorial). N. Engl. J. Med.

279:1053-1054, 1968.

84. Finch,S.C.: Clinical symptoms and signs of infectious mononucleosis in Infectious

Mononucleosis, Blackwell Scientific Publications, Oxford, 1969, p. 19-46.

85. Finch, S.C.: Laboratory findings in infectious mononucleosis in Infectious. Mononucleosis,

Blackwell Scientific Publications, Oxford, 1969, p. 47-62.

1.

86. Prosnitz, L., Kawasaki, S., Cohen, G.S., Dineen, J.L., Perillie, P.E., Finch, S.C.: Ethyl

palmitate-induced splenic destruction. J. Reticuloendothel. Soc. 6:487-497, 1969.

87. Kaplan, S.S., Perillie, P.E., Finch, S.C.: The effect of chtoramphenicol on human leukocyte

phagocytosis and respiration. Proc. Soc. Exp. Biol. Med. 130:839-843, 1969.

88. Finch, S.C., Hoshino, T., Itoga, T., Ichimaru, M., Ingram, R. H., Jr.: Chronic lymphocytic

leukemia in Hiroshima and Nagasaki, Japan, Blood. 33:79-86, 1969.

89. Kaplan, S.S., Finch, S.C.: Studies on the mechanism of chloramphenicol impairment of human

leukocyte function. Pro. Soc. Exp. Biol. Med. 134:287-290, 1970.

90. Perillie, P.E., Finch, S.C.: Muramidase studies in Philadelphia-chromosome- positive and

chromosome-negative chronic granulocytic leukemia. N. Engl. J. Med. 283:456-458, 1970.

91. Wright, M.C., Nelson, R.A., Finch, S.C.: The effects of a cobra venom factor and ethyl

palmitate on the prolongation of survival of heterologous erythrocytes. Yale J. Biol. Med.

43:173-176, 1970.

92. Finch, S.C., Hoshino, T., Itoga, T., Ichimaru, M., Ingram,R.H.: Chronic lymphocytic

leukemia, Hiroshima-Nagasaki, 1946-65. Hiroshima lgaku. 23:544- 549, 1970.

93. Hoshino, T., Kato, H., Finch, S.C., Hrubec, Z.: Leukemia in offspring of atomic bomb

survivors, Hiroshima-Nagasaki, 1946-63. Hiroshima Iagku. 23:536- 432, 1970.

94. Covey, W., Perillie, P.E., Finch, S.C.: The origin of tear lysozyme. Proc. Soc. Exp. Biol.

Med. 137:1362-1363, 1971.

95. Fischer, D.S., Parkman, R., Finch, S.C.: Acute iron poisoning in children. The problem of

appropriate therapy. JAMA. 218:1179-1184, 1971.

96. Finch, S.C.: Granulocytopenia (Chapter 75) in Hematology, W.J. Williams, E. Beutler, A.J.

Erslev, R.W. Rundles (editors), McGraw Hill, Inc., 1972, pp. 628- 652.

97. Finch, S.C.: Granulocytosis (Chapter 76) in Hematology, W.J. Williams, E. Beutler, A.J.

Erslev, R.W. Rundles (editors), McGraw Hill, Inc., 1972, pp. 6 5 4 - 663.

98. Finch, S.C. Neutropenia, .n Current Therapy, H.F. Conn (editor), W.B. Saunders Co.,

Philadelphia, 1972, pp. 250-252.

99. McPhedran, P., Finch, S.C., Nemerson, Y.R., Barnes, M.G.: Alpha-2 globulin "spike" in

renal carcinoma. Ann. Intern. Med. 76:439-441, 1972.

100. Spencer, R.P., McPhedran, P., Finch, S.C., Morgan, W.S.: Persistent neutrophilic leukocytosis

12

associated with idiopathic functional asplenia. J. Nucl. Med. 13:224-226, 1972.

101. Kawasaki, S., Finch, S.C.: Study of mechanism of ethyl palmitate-induced splenic destruction.

J. Reticuloendothel Soc. 11:555-565, 1972.

102. Vietzke, W.M., Perillie, P.E., Finch, S.C.: Serum muramidase in patients with neutropenia.

Yale J. Biol. Med. 45:457-462, 1972.

103. Lippman, M.E., Finch, S.C.: A quantitative study of muramidase distribution in normal and

nitrogen mustard-treated rats. Yale J. Biol. Med. 140:460-470. 1972.

104. Kaplan, S.S., Finch, S.C., Basford, R.E.: Polymorphonuclear leukocyte activation: Effects of

phospholipase C. Proc. Soc. Exp. Biol. Med. 140:540- 543, 1972.

105. Castro, 0., Andriole, V.T., Finch, S.C.: Whole blood phagocytic and bactericidal activity for

staphylococus aureus. 1. Lab Clin. Med. 80:857-870, 1972.

106. Finch, S.C., Clemett, A.R., Kawasaki, S.: Radiological visualization of ethyl palmitate induced

spenic atrophy. Br. J. Exp. Path. 53:621-624, 1972.

107. Finch, S.C.: Sickle cell survey (editorial). Conn. Med. 37:460-461, 1973.

108. Finch, S.C., Jonas, A.M.: Ethyl palmitate-induced bartoneUosis as an index of functional

splentic ablation. J. Reticuloendothel. Soc. 13:20-26, 1973.

109. Perillie, P.E., Finch, S.C.: Lysozyme in leukemia. Med. Clin. North Am. 57:395-407, 1973.

110. Perillie, P.E., Khan, K., Finch, S.C.: Serum lysozyme in pulmonary tuberculosis. Am. J. Med.

Sci. 265:297-302, 1973.

Ill. Flyer, R.H., Finch, S.C.: The effects of prostaglandin El on human granulocyte metabolism

during phagocytosis. J. Reticuloendothel. Soc. 14:325-331, 1973.

112. Perillie, P.E., Finch, S.C.: Lisozime en leucemia. Clinicas Medicas de Norteamerica.

57:395-407, 1973.

113. Castro, 0., Orlin, J., Rosen, M.W., Finch, S.C.: Survival of human sickle-cell erythrocytes

in heterologous species: Response to variations in oxygen tention. Proc. Nat. Acad. Sci. USA

70:2356-2359, 1973.

114. Pascual, R.S., Gee, J.B.L., Finch, S.C.: Usefulness of serum lysozyme measurement in

diagnosis and evaluation of sarcoidosis. N. Engl. J. Med. 289:1074-1076, 1973.

115. Goldenfarb, P.B., Finch, S.C.: Thrombotic thrombocytopenic purpura: A ten- year survey.

13

JAMA. 226:644-647, 1973.

116. Finch, S.C,: Eosinophilic leukemia (editorial). Conn. Med. 38:239, 1974.

117. Castro, 0., Finch, S.C.: Splenic infarction in sickle-cell trait: Are whites more susceptible'?

(correspondence). N. Engl. J. Med. 291:630-631, 1974.

118. Finch, S.C., Castro, 0., Cooper, M., Covey, W., Erichson, R., McPhedran, P.:

Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am. J. Med.

56:4-12, 1974.

119. Grann, V., Erichson, R., Flannery, J., Finch, S.C., Clarkson, B.: The therapy of acute

granulocytic leukemia in patients more than 50 years old. Ann. Int. Med. 80:15-20, 1974.

120. Finch, S.C., Castro, 0., Lippman, M.E., Donadio, J.A., Perillie, P.E.: Lysozyme in

leukopathic states, in Lysozyme, EF Osserman, RE Canfield, and S. Beychok (editors),

Academic Press, New York, 1974, pp. 335-345.

121. Perillie, P.E., Finch, S.C.: Lysozyme measurements in acute leukemia: Diagnostically useful?,

in Lysozyme, EF Osserman, RE Canfield and S. Beychok (editors), Academic Press, New York,

1974, pp. 359-372.

122. Pascual, R.S., Perillie, P.E., Gee, J.B., Finch, S.C.: Serum and urine lysozyme studies in

sarcodosis, in Lysozvme,. EF Osserman, RE Canfield, and S Beychok (editors), Academic Press,

New York, 1974, pp. 331-398.

123. Castro, 0., Orlin, J., Finch, S.C.: The effect of hemoglobin carbamylation on the survival of

human sickle cell erythrocytes in rats. Yale J. Biol. Med. 1:55-60, 1974.

124. Castro, 0., Nash, I., Finch, S.C: Congenital dyserythropoietic anemia type 1: Report of a case

with increased erythrocyte agglutinability by anti-i serum. Arch. Intern. Med. 134:346-341,

1974.

125. Finch, S.C., Castro 0., Orlin, J., Rosen, M.W., Aponte, L.: The development of a

heterologous transfusion technique: Application to sickle cell disease. Conn. Med. 38:338-341,

1974.

126. Castro, 0., Rosen, M.W., Finch, S.C.: Mechanism of ethyl palmitate and cobra venom factor

enhancement of heterologous erythrocyte survival. Proc. Soc. Exp Biol. Med. 147:106-109,

1974.

127. Castro,O., Finch, S.C., Osbaldiston,G.: Sickle cell resistance to in vivo hypoxia. Nature.

251:620-621, 1974.

14

128. Castro, 0., Roth, R., Orlin, J., Finch, S.C.: Human sickle cells in a heterologous species: A

model for the screening of antisickling agents, in Erythrocyte Structure and Function, Proc.

Third Int. Conf. on Red Cell Metabolism and Function, Ann Arbor, Michigan, '974, GJ Brewer,

editor, Alah R. Liss, Inc., New York, 1975, Vol 1, pp. 455-464.

129. Finch, S.C., Beebe, G.W.: Aging, J. Radiat. Res. 16 (supp):108- 12 1, 1975.

130. Aleali, S.H., Castro, 0., Spencer, R.P., Finch, S.C.: Sideroblastic anemia with splenic abscess

and fatal thromboemboli after splenectory. Ann. Intern. Med. 83:661-663, 1975.

131. Castro, 0., Osbaldiston, G.W., Aponte, L., Roth, R., Orlin, J., Finch,S.C.: Oxygen dependent

circulation of sickle erythrocytes. J. Lab CLin. Med. 88:732- 744, 1976.

132. Dobbins, J.W., Binder, H.J., Spiro, H.M., Finch, S.C.: Serum lysozyme in inflammatory

bowel disease. Gastroenterology. 70:469-476, 1976.

133. Finch, S.C.: Granulocytopenia (Chapter 83) in Hematology, W.J. Williams (editor), 2nd

Edition, McGraw Hill, Inc., 1976, pp. 717-746.

134. Finch, S.C.: Granuloqgtosis.Chapter 84) in Hematology, W.J. WIlliams (editor) 2nd Edition,

McGraw Hill, Inc., 1976Vp. 746-755.'

135. Finch, S.C.: Agranulocytosis, in The Merck Manual. Ed. 13, Merck, Sharp and Dohme

Research Laboratories, New Jersey , 1977, pp. 321-324.

136. Finch, S.C.: Lymphocytopenia, in The Merck Manual.Ed. 13, Merck, Sharp and Dohme

Research Laboratories, New Jersey , 1977, pp. 324-325.

137. Lundberg, W.B., Cadman, E.D., Finch, S.C., Capizzi, R.L.: Renal failure secondary to

leukemic infiltration of the kidneys. Am. J. Med. 62:636-642, 1977.

138. Finch, S.C., Kawasaki, S., Perillie, P.E., Castro, 0., Orlin, J.: Hyperfunction and hypofunction

of the reticuloendothelial system, in Topics of Hematology, Proc. 16th Int. Congr. of

Hematology, Sero, Takaku, Irino (editors), Excerpta medica, Amsterdam-Oxford, 1977, pp.

548-549.

139. Finch, S.C., Hoshino, J T., Lamphere,J.P., Ishimaru, T.: Peripheral blood changes preceding

the development of leukemia in atomic bomb survivors in Hiroshima and Nagasaki, in

Topics in Hematology. Proc. 16th Int. Congr. of Hematology, Seno, Takaku, Irino (Editors),

Excerpta Medica, Amsterdam-Oxford, 1977, pp. 97-98.

140. Yamashita, H., Ogita, Z., Hamilton, H.B., Yamakido, M., Finch, S.C., Satoh, C.:

Immunochemical studies of A-bomb survivors and their families. Report on the investigation

concerning atomic bomb injuries, 1977, Jpn. Public Health Assoc., 1977, pp. 109-112.

15

141. Azikiewe, A.N., Castro, 0., Osbaldiston, G.W., Finch, S.C.: Survival of human 51Cr

erythrocytes in Guinea Pigs. Br.J. Exp. Pathol. 59:248-253, 1978.

142. Pinkston, J.A., Finch, S.C., lida, S., Caplan, R.A.: An agarose plate method for the study of

human T and B lymphocyte migration. Jpn. J.Exp. Med. 48:279- 282, 1978.

143. Finch, S.C.: Hiroshima & Nagasaki: A review of 30 years of Study. Proceedings of the Sixth

International Congress of Radiation Research (ed. Okada,S., Imamura, M., Terashima, T., and

Yamaguchi,H.) Tokyo, 1979, pp. 50-8.

144. Finch, S.C.: The effect of whole body radiation on the aging process in man. Recent Advances

in Gerontology (ed. Orima, H., Shimada, K., Iriki, M., and Maeda, K.) Exerpta Medica,

Amsterdam, 1979, pp. 436-7.

145. Finch, S.C.: The medical legacy of August 1945, Dartmouth Alumni Magazine 72, 25-9, 1979.

146. Finch, S.C.: The status of granulocyte transfusions. J. Jpn. Soc.Blood Transfusion, 24,136-45,

1979.

147. Pinkston, J.A., Finch, S.C.: A method for the non-specific esterase stlaiý.;-of-T and B

lymphocytes and monocytes following in vitro migration under agarose. Stain-Vehnol. 54,

233-9, 1979.

148. Finch, S.C.: The study of atomic bomb survivors in Japan. Am. J. Med. 66, 899- 901, 1979.

149. Finch, S.C., Moriyama, I.M.: The delayed effects of radiation exposure among atomic bomb

survivors, Hiroshima and Nagasaki: a brief summary. J. Hiroshima Med. Asso. 33, 83-94,

1980.

150. Finch, S.C.: A review of immunologic and infectious disease studies at ABCC- RERF. J.

Hiroshima Med. Assoc. 34, 52-65, 1981.

151. Pinkston, J.A., Finch, S.C.: Human T & B lymphocyte migration under agarose: differences

in the characteristics of migrating cells and migration patterns. Japan J. Exp. Med. , 51,

261-270, 1981.

152. Finch, S.C.: Agranulocytosis, int The Merck Manual. Ed. 14, Merck, Sharp, and Dohme

Research Laboratories, New Jersey, 1982, pp. 1133-1136.

153. Finch, S.C.: Lymphocytopenia, in The Merck Manual, Ed. 14, Merck, Sharp, and Dohme

Research Laboratories, New Jersey, 1982, pp. 1136-1137.

154. Finch, S.C.: Neutropenia (Chapter 87) in HematologyW.J. Williams (editor), 3rd Edition, Mc

Graw Hill, Inc., 1983, pp. 773-793.

16

155. Finch, S.C.: Neutrophilia (Chaper 88) in Hematology._W.J. Williams (editor), 3rd Edition,

McGraw Hill, Inc., 1983, pp. 794-801.

156. Finch, S.C.: Cancer in atomic bomb survivors, in The Final Epidemic:

Scientists and Physicians on N-uclear War, 1981, Education Foundation for Nuclear Science,

Chicago, pp. 151-165.

157. Finch, S.C.: Neutropenia, in Current Therapy.1982, H.F. Conn (editor) W.B. Saunders Co.,

Philadelphia, pp. 266-269.

158. Finch, S.C.: Hiroshima: Immediate and Long-Range Medical Effects in Proceedings of the

Symposium. The role of the academy in addressing the Issues of Nuclear War, 1982, Hobart

and William Smith Colleges, Geneva, N.Y., pp. 23-31.

159. Pinkston, J.A., Finch, S.C.: An evaluation of certain factors which influence the in vitro

migration of subpopulations of human lymphocytes. Japan J. Exp. Med., 52, 153-161, 1982.

160. Finch, S.C., Gekowski, K.: Agranulocytosis in Current Therapy in

Hematology/Oncology, B.C. Decker, Inc., Philadelphia and Toronto, 1983, pp. 62-67.

161. Yamada Y., Ichimaru,M ,- Finch, S.C., Kinoshita,K., Tomonaga, M., Pinkston, J.A.:

Determination of human peripheral blood mononuclear cell-mediated cytotoxicity by an agarose

plate method: Spontaneous release of a soluble cytotoxic factor against SRBC targets from

monocytes. Acta Haematol Jpn, 46, 164-182, 1983.

162. Finch, S.C.: Ionizing radiation and drugs in the pathogenesis of lymphoid neoplasia, in The

Influence of the Environment on Leukemia and Lymphoma Subtypes, Raven Press, New York,

1983, pp. 207-223.

163. Finch, S.C.: Leukemia and Lymphoma in Atomic Bomb Survivors, Radiation

Carcinogenesis: Epidemiology and Biologic Significance, edited by J.D. Boice, Jr. and

J.F.Fraumeni, Jr., Raven Press, New York, 1984, pp. 3 6 -4 4 .

164. Choshi, K., Takaku, I., Mishima, H., Takase, T., Neriishi, S., Finch, S.C., Otake, M.:

Opthalmologic changes related to radiation exposure and age in adult health study sample,

Hiroshima and Nagasaki, Rad Res, 96,560-579, 1983.

165. Finch, S.C., Gekowski,K.: Agranulocytosis in Current Therapy in Internal Medicine 1984,

Philadelphia, B.C. Decker, Inc.

166. Finch, S.C., Gekowski, K.: Neutropenia in Current Emergency Medical Therapy 1985, R.F.

Edlich (ed.), Appleton-Century-Crofts.

167. Pinkston, F.A., Finch, S.C.: Effect of colchicine on the migration of human lymphocyte

17

sub-populations under agarose. Jpn J Exp Med 55:201-6, 1985.

168. Finch, S.C.: Acute radiation syndrome. JAMA 258:664-7, 1987.

1

169. Tomonaga, M., Kuriyama, K., Ichimaru, M., Matsuo, T., Finch, S.C., Imanaka, F., Kuramoto,

A., Kamada, N.: Reassessment of diagnosis and subtyping of leukemias among atomic bomb

survivors: IV. Combined analysis of Hiroshima and Nagasaki cases. Hiroshima Igaku

41:498-503, 1988.

170. Matsuo, T., Tomonaga, M., Bennett, J.M., Kuriyama, K., Imanaka, F., Kuramoto, A.,

Kamada, N., Ichimaru, M., Finch, S.C., Pisciotta, A.V., Ishimaru, T: Reclassification of

leukemia among A-Bomb survivors in Nagasaki using French- American-British (FAB)

classification for acute leukemia. Jpn. J. Clin. Oncol. 18:91-96, 1988.

171. Sasagawa, S., Yashimoto, Y., Toyota, E., Neriishi, S., Yamakido, M., Matsuo, M.,

Hosoda,Y., and Finch, S.C.: Phagocytosis and bactericidal activities of leukocytes in whole

blood from atomic bomb survivors, Rad Res, 124, 103-106. 1990.

172. Finch, S.C., Radiation Injury, in Harrison's Principles of Internal Medicine, 12th Edition.

edited by Wilson, J.D., Braunwald, E., et a[, McGraw-Hill Book Company, New York, 1991,

pp. 2204-2208.

173. Finch, S.C., and Linet, M.S.: The Chronic Leukemias. Bailliere's Clinical Haematology, 5

(1), 27-57, 1992.

174. Otake, M., Finch S.C., Choshi, K., Takaku, I., Mishima, H., Takase, T., Radiation-Related

Ophthalmologic Changes and Aging among Hiroshima and Nagasaki A bomb survivors: A

Reanalysis. Radiation Research, 131, 314-324, 1992.

175. Finch, S.C., Radiation Injury, in Harrison's Principles of Internal Medicine, 13th Edition, edited

by Isselbacher, K.J., Braunwald, E, et al, McGraw - Hill Book Company, New York, 1994, pp.

2482-2487.

176. Finch, S.C., Nuclear Threat, in The Albert Schweitzer Institute for the Humanities Reverence

for Life: Albert Schweitzer and Global Health from Lambarene to the 21st Century. 1995, In

Press.

177. Finch, S.C., How Long Can We Live? in the Yale Journal of Biology and Medicine 67, 1994,

pp 15-21.

178. Lindee, M. Susan, Suffering Made Real: American science and the survivors at Hiroshima,

University of Chicago Press, Chicago, 1995 (book review by S. C. Finch) N. Engl. J. Med.

1995, In Press.

18

ABSTRACTS AND PRELIMINARY NOTES

1. Finch, S.C., Haskins, D., Finch, C.A.: Blood production and iron reserves in man. Fed. Proc.

8:45, 1949'.

2. Finch, S.C., Ross, J.F.: The significance of plasma iron turnover rate. FedProc. 11:414, 1952.

3. Finch, S.C., Ross, J.F.: The significance of plasma iron turnover. J.Clin. Invest. 31:627, 1952.

4. Finch,S.C., Ross, J.F., Ebaugh, F.G., Jr.: Immunologic mechanisms of leukocyte

abnormalities. Proc. Am. Soc. Clin. Invest. 32:567, 1953.

5. Finch, S.C., Ross,J.F.: Immunologic mechanisms of leukocyte abnormalities. Clin. Res. Proc.

1:13, 1953.

6. Finch, S.C., Ross, J.F.: The relationship of plasma iron to the kinetics of iron metabolism.

Clin. Res. Proc. 1:61, 1953.

7. Finch, S.C., Ross, J.F., Street, R.B., Strieder, J.W.: Thymoma and refractory anemia. Clin.

Res. Proc. 2:29, 1954.

8. Freireich, E.J., Ross, J.F., Bayles, T.B., Emerson, C.P., Finch, S.C.: The mechanism of the

anemia associated with rheumatoid arthritis. Clin. Res. Proc. 2:54, 1954.

9. Finch, S.C., Hollingsworth, I.W.: Leukocyte response to sera prepared against granulocyte

cytoplasmic fractions. Fed. Proc. 14:462, 1955.

10. Finch, S.C., Kline, D.L. : Leukocyte survival in polycythemia vera. Clin. Res. Proc. 3:97,

1955.

11. Finch, S.C., Hollingsworth, J.W.: Study of leukocyte dynamics by means of cross circulation

in rates. Clin. Res. Proc. 4:8, 1956.

12. Hollingsworth, J.W., Finch, S.C.: Effect of cross circulation with normal rats on experimental

E. coli bacteremia in irradiated rats. Clin. Res. Proc. 4:19, 1956.

13. Hollingsworth, J.W., Finch, S.C., Beeson, P.B.: The viability of transfused leukocytes in

irradiated rats. Clin. Resde. Proc. 4:86, 1956.

14. Dahaher, T.H., Friou, G.J., Finch, S.C.: Fluoresce in labeled antigloublin test applied to

leukocyte immunology. Clin. Res. Proc. 5:9, 1957.

15. Friou, G.J., Finch, S.C., Detre, K.D.: Nuclear localization of a factor from disseminated lupus

serum. Fed. Proc. 16:413, 1957.

19

16. Finch, S.C., Detre, K.D.: Leukotoxicity of pathologic sera and certain drugs. Clin. Res.,

6:196, 1958.

17. Welch, A.D., Handschumacher, R.E., Finch, S.C., Voklle, R.L., Green, R.E., Peters, L.:

Renal excretion characteristics of azauridine-C14. Fed. Proc. 17:419, 1958.

18. Detre, K.D., Finch, S.C.: Nuclear lysis by lupus serum in the absence of complement. Clin.

Res. 7:265, 1959.

19. Brody, J.1., Finch, S.C.: Candida reacting antibody in the serum of patients with lymphomas

and related disorders. J. Clin. Invest. 38:992, 1959.

20. Brody, J.I., Finch, S.C.: Human platelets in immune adherence. Clin. Res. 8:15, 1960.

21. Perillie, P.E., Finch, S.C.: Cellular response to local inflammation in leukopathic states. Clin.

Res. 8:18, 1960.

22. Finch, S.C., Detre, K.D.: Lysozyme osmotic fragility of normal and leukemic leukocytes.

Clin. Res. 8:208, 1960.

23. Calabresi, P., Friou, G., Finch,S.C.: Characterization of rheumatoid states by study of

antinuclear factors. Clin. Res. 8:197, 1960.

24. Brody, M.1., Finch, S.C.: Serum factors in acquired hemoloytic anemia in patients with

lymphoma and leukemia. J. Clin. Invest. 39:975, 1960.

25. Calabresi, P., Finch, S.C., Cardoso, S.S., Welch, A.D.: Preliminary clinical experiences with

5-iododeoxyuridine. Proc. Am. Assoc. Cancer Res. 3:99, 1960.

26. Finch,S.C., Cardoso, S.S., Calabresi, P. Clement, D.H., Handschumacher, R.E., Welch, A.D.:

Preliminary observations on the effect of 6-azauridine in patients with neoplastic diseases. Proc.

Am. Assoc. Cancer Res. 3:110, 1960.

27. Handschumacher, R.E., Cardoso, S., Jaffe, J.3., Liebow, A.A., Calabresi, P., Finch, S.C.,

Welch, A.D.: Biochemical and pharmacological effects of 6- azauridine in animal and human

subjects. Proc. Am. Assoc. Cancer Res. 3:116, 1960.

28. Von Essen, C.F., Calabresi, P., Kilgerman, M.M., Finch, S.C.: Combined treatment of

advanced neoplastic disease with 5-fluorouracil and radiation. Proc. Am. Assoc. Cancer Res.

3:159, 1960.

29. Welch, A.D., Jaffe, J.J., Cardoso, S.S., Finch,S.C., Calabresi, P., Liebow, A.A., Prusoff,

W.H.: Studies on the pharmacology of 5-iododeoxyuridine in animals and man. Proc. Am.

Assoc. Cancer Res. 3:161, 1960.

20

30. Finch, S.C.: Delayed radiation effects in Hiroshima and Nagasaki. Nippon Acta. Radiol.

21:421-422, 1961.

31. Perillie, P.IE., Finch, S.C.: Leukocyte alkaline phosphatase activity in acute leukemia. Clin.

Res. 9:164, 1961.

32. Fink, M.E., Calabresi, P., Finch, S.C.: Granulocyte response to endotoxin in myeloroliferative

disorders. J. Clin. Invest. 40:1038, 1961.

32a. Perillie, P.E., Nolan, J.P., Finch, S.C.: The local exudative cellular response in uncontrolled

diabetes. Clin. Res. 9:165, 1961.

33. Finch, S.C., Lamphere, J.P.: Serum lysozyme and leukopoiesis. Acta Haematol. Jpn. 25

(Suppl): 4 7 8 , 1962.

34. Finch, S.C.: Cellular reaction to infection in normal, leukemic and diabetic subjects. J. Jpn.

Soc. Intern. Med. 51:51-52, 1962.

35. Kanamitsu, M., Gotoh, H., Morita,J., Nagao, M., Tairu, T., Finch, S.C., Kato, H., Onishi,

S.: Study on the doctrine of original antigenic sin and its application for examination of the

effect of atomic bomb radiation on antibody production. Rep. 10th Natl. Congr. Jpn. Biol. Sec.

69-70, 1962 (in Japanese.

36. Rogoway, M.W., Finch, S.C.: Serum lysozyme and leukopoiesis. Clin. Res. 11:198, 1963.

37. Groch, G.S., Rogoway, W., Fischer, D., Finch, S.C.: Studies concerning the pathogenesis of

autoerythrocyte purpura. Blood. 22:814, 1963.

38. Perillie, P.E., Finch S.C.: Quantitative studies of the local exudative cellular reaction to

inflammation in acute leukemia. Blood. 22:839-840, 1963.

39. Finch, S.C., Hoshino, T., Ichimaru, M., [toga, T., Grubec, Z.: Leukemia and lymphoma

following exposure to ionizing radiation in Hiroshima and Nagasaki, Proc. Xth Congr. of the

Intl. Soc. of Hematology. Stockholm, Sweden, 1964.

40. Groch, G.W., Perillie, P.E., Finch, S.C.: Reticuloenmdothelial function in patients with

hematologic disorders. Proc. Xth Congr. of the Intl. Soc. of Hematology, Stockholm, Sweden,

1964.

41. Perillie, P.E., Groch, G.S., Briggs, R.S., Finch, S.C.: Reficuloendothelial phagocytic function

in patients with hypersplenism and related disorders. J. Clin. Invest. 44: 1085, 1965.,

42. Binder, H.J., Finch, S.C., Spiro, H.M.: Vitamin E deficiency in steatorrhea. Gastroenterology,

48:806, 1965.

21

43. Fink, M.E., Finch, S.C.: Serum muramidase and granulocyte turnover. Clin. Res. 14:316,

1966.

44. Perillie, P'.E., Kaplan, S.S., Lefkowitz, E., Finch, S.C.: Muramidase lysozyme activity in

leukemia. Blood. 28:1000-1-001, 1966.

45. Prosnitz, L.R., Kawasaki, S., Dineen, J.J., Braverman, I.M., Perillie, P.E., Finch, S.C.: The

effects of ethyl palmitate-inducated splenic destruction on rodent hemolytic anemias. J. Clin.

Invest. 46:1106, 1967.

46. Kaplan, S.S., Perillie, P.E., Finch, S.C.: Effects of chloramphenicol on leukocyte phagocytosis

and respiration. Clin. Res. 15:282, 1967.

47. Perillie, P.E., Kaplan, S.S., Finch, S.C.: Evaluation of leukopoiesis in megaloblastic anemia

by measurement of serum muramidase, Clin. Res. 15:285, 1967.

48. Kaplan, S.S., Perillie, P.E., Finch, S.C.: Chloramphenicol inhibition of leukocyte oxidase.

Blood. 30:856, 1967.

49. Perillie, P.E., Finch, S.C.: Therapeutic implications of muramidase changes in acute leukemia.

Blood. 30:858, 1967,.

50. Kaplan, S.S., Perillie, P.E., Finch, S.C.: Reversal of chloramphenicol inhibition of leukocyte

oxidative glycolysis by NAD. Clin. Res. 16:305, 1968.

51. Vietzke, W.M., Finch, S.C.: Serum muramidase in neutropenic states. Clin. Res. 16:543,

1968.

52. Finch, S.C., Kawasaki, S., Prosnitz, L., Clemett, A.R., Jonas, A.M., Perillie, P.E.: Ethyl

palmitate induced medical splenectomy in rats: XII Cngr. Intl. Soc. of Hematology, New York,

p. 138, 1968.

53. Castro, 0., Andriole, V., Finch, S.C.: Evaluation of blood phagocytic and bactericidal

activities. Clin. Res. 17:607, 1969.

54. Castro, 0., Finch, S.C.: Blood bactericidal activity in malignant hematologic disorders. Clin.

Res. 17:599, 1969.

55. Finch, S.C., Wright, D.M.: Enhancement of heterologous erythrocyte survival. Blood. 34829,

1969.

56. Perillie, P.E., Finch, S.C.: Studies of muramidase in Ph'-negative chronic granulocytic

leukemia. Clin. Res. 17:465, 1969.

22

57. Castro, 0., Cordero, L., Jr., Finch, S.C.: Phagocyticand bactericidal capacity of maternal and

neonatal blood. Clin. Res. 18:437, 1970.

58. Castro, O.,' Perillie, P.E., Finch, S.C.: Lysozymen in relationship to the clinical characteristics

of adult acute leukemia. XII Intl. Congr. of Hematology, Munich, August 2-8, 1970, Abstract

volume, p. 231, J.F. Lehmanns Verlag, Munich.

59. Kaplan, S.S., Nemerson, Y., Finch, S.C.: Membrane lipids and leukocyte glucose metabolism.

J. Clin. Investg. 49:50 a, 1971.

60. Castro, 0., Perillie, P.E., Finch, S.C.: Relationship of muramidase to karyotype and disease

stage in chronic granulocytic leukemia (CGL). Clin. Res. 19:414.1971.

61. Flyer, R.H., Finch, S.C.: The effects of prostaglandin El on human granulocytes during

phagocytosis. Clin. Res. 19:726, 1972.

62. Pascual, R.S., Perillie, P.E., Sulavik, S., Donadio, J.A., Gee, J.B.L., Finch, S.C.: Lysozyme

studies in sarcoidosis. Ann. Intern. Med. 76:880, 1972.

63. Castro, 0., Aponte, L., Finch, S.C.: An animal system for study of the survival of human

sickle cells. Clin. Res. 21:548, 1973.

64. Orlin, J., Castro, 0., Finch, S.C.: Survival of human sickle trait erythrocytes in a heterologous

species. Clin. Res. 21:969, 1973.

65. Grann, V., Finch, S.C., Clarkson, B., Erichson, R., Rosenberg, A.: Acute granulocytic

leukemia in patients over 50. Ann. Intern. Med. 78:824, 1973.

66. Castro, 0., Orlin, J., Rosen, M.W., Finch, S.C.: Oxygen dependent circulation of sickle cells.

Clin. Res. 22:386A, 1974.

67. Capizzi, R., Castro, 0., Aspnes, G., Bobrow, S., Bertino, J., Finch, S.C., Pearson, H.:

Treatment of acute lymphocytic leukemias (ALL) with intermittent high dose methotrexate

(MTX) and asparaginase (A'ase). Proc. Am. Assoc. Cancer Res. 15:182, 1974.

68. Castro, 0., Orlin, J., Rosen, M.W., Finch, S.C.: In vivo recirculation of sickled erythrocytes.

55th Annual Session of the American College of Physicians, New York City, April 1-4, 1974.

69. Castro, 0., Osbaldiston, G., Aponte, L., Finch, S.C.: Liver and spleen uptake of human sickle

cells in hypoxic animals. Blood. 44:944, 1974.

70. Roth, R., Castro, 0., Finch, S.C.: Enhancement of sickle cell survival by zinc and nitrogen

mustard. Clin. Res. 22:702a, 1974.

23

71. Bairn, D., Castro, 0., McPhedran, P., Finch, S.C.: Drug-induced hemoloysis of

G6PD-deficient human erythrocytes in rat hosts. CLin. Res. 22:699a, 1974.

72. Rosen, M.W., Castro, 0., Finch, S.C.: Study of human hereditary spherocytosis in a

heterologous species. J. Clin. Invest. 53:66a, 1974.

73. Finch, S.C., Hamilton, H.B.: Atomic bomb radiation studies in Japan. Science 192:845, 1976.

74. Finch, S.C., Kawasaki, S., Perillie, P.E.,Castro, 0., and Orlin, J., Hyperfunction and

hypofunction of the reticuloendothelial system, Proceedings XVI International Congress of

Hematology, Tokyo, September 5-11, 1976.

75. Finch, S.C.: A thirty-year follow-up of survivors of Hiroshima and Nagasaki. World Health

in Human Perspective, Philadelphia, 15, Sept. 1976.

76. Caplan, R.A., Finch, S.C.: Effect of colchicine on the agarose plate migration pattern of human

polymorphonuclear (PMW) leukocytes. Clin. Res. 24(56) 5:630A, 1976.

77. Finch, S.C, Hamilton, H.B.: Radiation of the young brain. Br. Med. J. 2(6101):1539, 1977.

78. Hoshino, T., Uchida, N., Takahashi, T., Horiuchi, T., Nagayama, S., Okada, H., Itani, S.,

Okada,T., Yamamoto, T., Finch, S.C.: Prognosis of polycythemia vera, with special reference

to leukemic transformation. Acta Haematol. Jpn. 41(2):314, 1978.

79. Pinkston, J.A., Finch, S.C.: The influence of serum factors on the relationships between

granulocyte migration and chemotaxis in an agarose plate system. Acta Haematol. Jpn.

41(2):355, 1978.

80. Finch, S.C., Pinkston, J.A., Hoshino, T.: The random migration characteristics of normal T

& B lymphocytes and lymphocytes from patients with chronic lymphocytic leukemia. XVII

Congr.Intl. Soc. Hematology/XV Congr.Intl. Soc. Blood Transfusion, 1978.

81. Finch, S.C.: Differences between Medical Associations in Japan and the United States.

Hiroshima City Medical Association Bulletin "Ishikai-dayori" Oct. 1978.

82. Ishimaru, T., Finch, S.C.: More on radiation exposure and multiple myeloma (letter to the

editor), N. Engl. 1. Med., 301,439-440, 1979.

83. Finch, S.C., Pinkston, J.A.: Random migration characteristics of human T and B lymphocytes

in vitro. Blood 54 (Suppl 1), 84a, 1979.

84. Finch, S.C.: Tumors of nonhematologic origin in atomic bomb survivors. Radiat. Biol. Res.

Commun. 14, 67-8, 1979.

24

85. Yamada, M.D., Pinkston, J.A., Neriishi, S., Finch, S.C.: The study of leukemic cell migration

using an agarose plate method, Nippon Ketsueki Gakkai Zasshi - Acta Haematol Jpn 43, 269,

1980.

86. Yamada, Y., Finch, S.C., Ishimaru, M.: Spontaneous cytotoxcity of human peripheral

mononuclear cells against SRBC targets using an agarose plate method. Proceedings of the

Fourth International Congress of Immunology, July 21-26, 1980.

87. Hiroshima and Nagasaki: The physical, medical and social effects of the atomic bombings, Basic

Book Inc. Publishers, New York, 1981 (book review by S.C. Finch)

N. Engl. J. Med. 305:1419-1420, 1981.

88. Lifrak, I.L., Finch, S.C., Stambaugh, J.E.: Serum tobramycin concentration in the fetal rat

following its intra-amniotic administration. Clin. Res. 312:630A, 1983.

89. Hilgarter, N.W., ed., Hemophilia in the Child and Adult, Masson Publishing USA, Inc., New

York, 1982. (book review by S.C. Finch) N. Engl. J. Med. 309, 565, 1983.

90. Bloom, Arthur L., ed., The Hemophilias, Churchill Livingstone, London and New York, 1982.

(book review by S.C. Finch) N. Engl. J. Med. 309, 565, 1983.

91. Finch, S.C.: Dual physician families at the Cooper Hospital/University Medical Center, Dual

Doctor Families 2, 5-6, September 1983.

92. Nathan, D.G., ed., Bone Marrow Transplantation, Clinics in Haematology, W.B. Saunders

Company Ltd., London, Vol. 12, 1983 (book review by S.C. Finch) N.Engl. J. Med.

310:1614-1615, 1984.

93. Blume, K.G. and Petz, L.D., ed., Clinical Bone Marrow Transplantation, Churchill Livingstone

Inc., New York, 1983 (book review by S.C. Finch) N. Engl. J. Med. 310:1614-1615, 1984.

94. Finch, S.C.: This Week's Citation Classic, Current Contents, 49, 20, 1985.

95. Schraeder, P.L., Wenger, J., Finch, S.C.: Antiepileptic drugs and chronic leukopenia: how low

can the white count go? Neurology (suppl 1) 37 1987.

96. Finch, S.C.: Skin Cancer on the Rise, The New Jersey Division Reporter, 43:1, 1 and 6, 1990.

97. Finch, S.C.: After Chernobyl, Camden County Medical Society Bulletin, 63, 11-14 1991.

98. Tomonaga M, Matsuo T, Carter RL, Bennett JM, Kuriyama K, Imanaka F, Kusumi S, Mabuchi

K, Kuramoto A, Kamada N, Ichimaru M, Pisciotta AV, Finch SC: Differential effects of atomic

bomb irradiation in inducing major leukemia types: Analyses of open-city cases including the

25

Life Span Study cohort based upon updated diagnostic systems and the Dosimetry System 1986,

RERF Update, 3 (3), 11, 1991.

ABCC-RERF TECHNICAL REPORTS

ABCC TR

12-61

17-61

26

Finch, SC, Jablon S: Ophthalmology programs at ABCC. A brief review and preliminary plan

Burrow GN, Hrubec Z, Finch SC: Background and status of clinical study to determine effects

of in utero exposure, Hiroshima-Nagasaki

Finch SC, Jablon S, Hrubec Z: Growth and development studies, Hiroshima and Nagasaki.

Research Plan

Finch SC: ABCC-JNIH Adult Health Study. Review of substudies June 1962 Hiroshima and

Nagasaki

Sawada H, Finch SC: Fertility study Hiroshima and Nagasaki, Provisional research plan

Finch SC, Lamphere JP, Jablon S: Serum lysozyme determinations April-June 1961 ABCC-JNIH

Adult Health Study Hiroshima

Finch SC, Anderson PS: ABCC-JNIH Adult Health Study. Report 3, 1958-60 Cycle

examinations, Hiroshima

Finch SC, Hoshino T, Hrubec Z, Itoga T, Nefzger MD: Operations manual for the detection

of leukemia and related disorders, Hiroshima-Nagasaki

Finch SC, Hrubec Z, Nefzer MD, Hoshino T, Itoga T: Detection of leukemia and related

disorders, Hiroshima-Nagasaki, Research Plan

Kanamitsu M, Morita K, Finch SC, Kato H, Onishi S: Serologic response of atomic bomb

survivors following Asian influenza vaccination

Hoshino T, Finch SC, Hrubec Z: Leukemia in children of irradiated parents, Hiroshima and

Nagasaki, August 1946-December 1961

Hoshino T, Kato H, Finch SC, Hrubec Z: Leukemia in offspring of atomic bomb survivors

1946-63, Hiroshima-Nagasaki

Finch SC, Hoshino T, Itoga T, Ichimaru M, Ingram RH: Chronic lymphocytic leukemia,

5-62

16-62

18-62

5-63

19-63

M1-65

5-65

4-66

2-67

3-67

18-67

Hiroshima-Nagasaki, 1946-65

1-70 Seki M, Finch SC: Effect of rice on oral iron absorption

8-74 Barerras RF, Finch SC: Peripheral blood leukocyte phagocytosis and respiratory response to

certain macronolecular substances in the ABCC-JNIH Adult Health Study, Hiroshima

19-75 Hoshino T, Finch SC, Lamphere JP, Ishimaru T: Peripheral blood changes preceding the

development of leukemia in atomic bomb survivors of Hiroshima and Nagasaki, 1947-62.

RERF Technical Reports (TR)

6-77 Caplan RA, Finch SC, lida S, Ozaki K, Hamilton HB: Low dose effects of colchicine and

vincristine on human polymorphonuclear leukocyte migration

16-77 Oesterle SN, Finch SC: Bone marrow cytology in Hiroshima atomic bomb survivors 5 years

following exposure

1-78 Pinkston, JA, Finch SC, lida S, Caplan R: An agarose plate method for the study of human T

and B lymphocyte migration

9-78 Caplan RA, Odoroff CL, Ozaki K, Hamilton HB, Finch SC: Lymphocyte cytotoxicity of

colchicine in Hiroshima atomic bomb survivors

16-78 Finch SC, Moriyama IM: The delayed effects of radiation exposure among atomic bomb

survivors, Hiroshima and Nagasaki: A brief summary

1-79 Pinkston JA, Finch SC: A method for the non-specific esterase staining of T & B lymphocytes

following in vitro migration under agarose

3-79 Pinkston JA, Finch SC: Human T & B lymphocyte migration under agarose: differences in the

characteristics of migrating cells and migration patterns

9-79 Ishimaru T, Finch SC: More on radiation exposure and multiple myeloma

22-79 Finch SC: A review of immunologic and infectious disease studies at ABCC-RERF

16-80 Pinkston JA, Finch SC: An evaluation of certain factors which influence the in vitro migration

of subpopulations of human lymphocytes

1-81 Pinkston JA, Finch SC: Effect of colchicine on the migration of human lymphocyte

subpopulations under agarose

27

3-81 Yamada YN, Ichimaru M, Finch SC, Kinoshita K, Tomonaga M, Pinkston JA: Determination

of human peripheral blood mononuclear cell-mediated cytotoxicity by an agarose plate method:

spontaneous release- of a soluble cytotoxic factor against SRBC targets from monocytes

8-81 Pinkston JA, Reed RL, Fincih SC: Effect of colchicine on human granulocyte random migration

and chemotaxis under agarose

8-82 Choshi K, Takaku I, Mishima H, Takase T, Neriishi S, Finch SC, Otake M: Ophthalmologic

changes related to radiation exposure and age in the Adult Health Study sample, Hiroshima and

Nagasaki

4-87 Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, Kamada N,

Ichimaru M, Finch SC, Piscoiotta AV, Ishimaru T: Reclassification of leukemia among A-bomb

survivors by French-American-British (FAB) classification. 1. Concordance of diagnosis in

Nagasaki cases by RERF members and a member of FAB cooperative group

23-88 Finch SC, Finch CA: Summary of the studies at ABCC-RERF concerning the late hematologic

effects of atomic bomb exposure in Hiroshima and Nagasaki

1-89 Sasagawa S, Yoshimoto Y, Toyota E, Neriishi S, Yamakido M, Matsuo M, Hosoda Y, Finch

SC: Whole-blood phagocytic and bactericidal activities of atomic bomb survivors, Hiroshima

and Nagasaki

9-91 Tomonaga M, Matsuo T, Carter RL, Bennett JM, Kuriyama K, Imanaka F, Kusumi S, Mabuchi

K, Kuramoto A, Kamada N, Ichimaru M, Pisciotta AV, Finch SC: Differential effects of atomic

bomb irradiation in inducing major leukemia types: Analyses of open-city cases including Life

Span Study cohort based upon up-dated diagnostic systems and the new dosimetry system (DS86)

18-91 Otake, M., Finch, S.C., Choshi, K, Takaku, I, Mishima, H, Takase, T, Radiation-related

ophthalmologic changes and aging among Hiroshima and Nagasaki A-bomb survivors: A

Reanalysis (approved as an RERF TR)

- Sasagawa, S., Kasagi, F., Finch, S.C., Hosoda, Y, Kusumi, S., Kodama, K, Age-related

variations in polymorphonuclear leukocyte generation of reactive oxygen species in a healthy

adult population as measured by chemiluminescence - (submitted for RERF TR consideration).

28